Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term colon cancer. Found 17 abstracts

Arora S, Huwe PJ, Sikder R, Shah M, Browne AJ, Lesh R, Nicolas E, Deshpande S, Hall MJ, Dunbrack RL, Golemis EA. Functional analysis of rare variants in mismatch repair proteins augments results from computation-based predictive methods. Cancer Biol Ther. 2017 Jul 03;18(7):519-33.   PMCID: PMC5639829
Ghatalia P, Nagarathinam R, Cooper H, Geynisman DM, El-Deiry WS. Mismatch repair deficient metastatic colon cancer and urothelial cancer: a case report of sequential immune checkpoint therapy. Cancer Biol Ther. 2017 Sep 02;18(9):651-4.   PMCID: PMC5663404
Malik F, Ali N, Durrani J, Mustafa SI, Denlinger C. Case series of multiple primary cancers in single individuals: diagnostic and therapeutic dilemmas. Journal of community hospital internal medicine perspectives. 2017 Oct;7(4):238-40.   PMCID: PMC5637644
Mirkin KA, Hollenbeak CS, Mohamed A, Jia Y, El-Deiry WS, Messaris E. Impact of perineural invasion on survival in node negative colon cancer. Cancer Biol Ther. 2017 Sep 02;18(9):740-5.   PMCID: PMC5663408
Thompson MD, Lubet RA, McCormick DL, Clapper ML, Bode AM, Juliana MM, Moeinpour F, Grubbs CJ. Lack of chemopreventive efficacy of metformin in rodent models of urinary bladder, head and neck, and colon/intestine cancer. Oncology Letters. 2017 Sep;14(3):3480-6.   PMCID: PMC5587978
Zhang J, Zhou L, Zhao S, Dicker DT, El-Deiry WS. The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia. Cell cycle (Georgetown, Tex). 2017 Jun 18;16(12):1193-200.   PMCID: PMC5499912
Zhao S, Tang H, Yan D, Fan J, Sun H, Wen Y, Yu F, Cui F, Zhang D, Xue Y, Liu C, Yue B, Chen J, Wang J, Wang X, Zhang M, Yu Y, Jiang W, Liu X, Mi Y, Zhou Z, Qin X, Peng Z. DDA1 promotes stage IIB-IIC colon cancer progression by activating NFkappaB/CSN2/GSK-3beta signaling. Oncotarget. 2016 Apr 12;7(15):19794-812.   PMCID: PMC4991419
Arora S, Yan H, Cho I, Fan HY, Luo B, Gai X, Bodian DL, Vockley JG, Zhou Y, Handorf E, Egleston BL, Andrake M, Nicolas E, Serebriiskii I, Yen TJ, Hall MJ, Golemis EA, Enders GH. Genetic Variants That Presdispose to DNA Double-strand Breaks in Lymphocytes from a Subset of Patients With Familial Colorectal Carcinomas. Gastroenterology. 2015 Sep 04;149(7):1872-1883 e9.   PMCID: 4663158
Dotan E, Meropol NJ, Zhu F, Zambito F, Bove B, Cai KQ, Godwin AK, Golemis EA, Astsaturov I, Cohen SJ. Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer. British Journal of Cancer. 2012 Feb;106(4):748-55.   PMCID: PMC3322945
Rajput A, Romanus D, Weiser MR, Ter Veer A, Niland J, Wilson J, Skibber JM, Wong YN, Benson A, Earle CC, Schrag D. Meeting the 12 Lymph Node (LN) Benchmark in Colon Cancer. Journal of surgical oncology. 2010 Jul;102(1):3-9.   PMCID: not NIH funded
Earle CC, Weiser MR, Ter Veer A, Skibber JM, Wilson J, Rajput A, Wong YN, Benson AB, Shibata S, Romanus D, Niland J, Schrag D. Effect of Lymph Node Retrieval Rates on the Utilization of Adjuvant Chemotherapy in Stage II Colon Cancer. Journal of surgical oncology. 2009 Dec;100(7):525-8.   PMCID: not NIH funded
Tong X, Yin L, Joshi S, Rosenberg DW, Giardina C. Cyclooxygenase-2 regulation in colon cancer cells: Modulation of RNA polymerase II elongation by histone deacetylase inhibitors. Journal of Biological Chemistry. 2005 Jan;280(16):15503-9.
Yao K, Gietema JA, Shida S, Selvakumaran M, Fonrose X, Haas NB, Testa J, O'Dwyer PJ. In vitro hypoxia-conditioned colon cancer cell lines derived from HCT116 and HT29 exhibit altered apoptosis susceptibility and a more angiogenic profile in vivo. British Journal of Cancer. 2005 Dec 12;93(12):1356-63.
Clapper ML, Szarka CE. Glutathione S-transferases - biomarkers of cancer risk and chemopreventive response. Chemico-Biological Interactions. 1998 Apr 24;112:377-88.
SutantoWard E, Arisawa Y, Tremiterra S, Sigurdson ER. Regional chemotherapy for colorectal hepatic metastases: Evidence for improved survival with new drug combinations. Annals of Surgical Oncology. 1996 Jan;3(1):36-43.
Su B, Kappler F, Szwergold BS, Brown TR. Identification of a putative tumor marker in breast and colon cancer. Cancer Research. 1993 Jan;53(8):1751-4.
Xiang J, Moyana T, Kalra J, Hamilton T, Qi YM. Construction and Characterization of a High-Affinity Chimeric Anticolorectal Carcinoma Antibody Ccm4. Molecular Biotherapy. 1992 Dec;4(4):174-83.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term colon cancer

colon cancer cells carcinoma apoptosis prognosis rectal-cancer survival therapy Neoplastic Gene Expression Regulation chemotherapy expression colorectal-cancer Neoplasm Staging dissection therapeutic use administration & dosage urothelial cancer floxuridine Cell Proliferation chromosomal instability chemoprevention recommendations phosphorus 31 infusion randomized phase-iii FUdR cytotoxicity Butyrate breast cancer cyclooxygenase 2 colorectal cancer Tumor Cell Line Nude Mice panitumumab copy number Colon carcinogenesis chimeric antibody adjuvant chemotherapy carcinoembryonic antigen angiogenesis DNA-Binding Proteins ratio Immunology carcinoid tumors human igg1 antibody genetics cetuximab b723 prevention drug effects p53 randomized trial clinical trials Atezolizumab field cancerization hereditary cancer Colonic Neoplasms resection specimens breast-cancer Male Dda1 growth fluorodeoxyuridine male f344 rats cyto-toxicity Female GST human ovarian-cancer Heterologous Transplantation esophageal cancer glycerol Pembrolizumab Hypoxia prognostic indicator experimental murine colitis folinic acid Fluorouracil multidrug-resistance tumorigenesis plus levamisole lymph nodes cancer Palbociclib outcomes genetic- phosphatidylcholine bevacizumab hepatic metastases National Cancer Data Base mitomycin C Antineoplastic Combined Chemotherapy Protocols solid tumors Postoperative Period variants of uncertain significance Multiple cancers rat curative resection lung-cancer Tumor necrosis factor (TNF) susceptibility metabolism immune-response mismatch repair number Colon cancer cells membrane phospholipid fluorouracil hypoxia genomic instability tumor marker adenocarcinoma Bioassay rare variant metformin COP9 Signalosome Complex Glycogen Synthase Kinase 3 beta aurora kinase A inhibition HT29 Cells NFkappaB p-glycoprotein urinary bladder cancer Western Blotting KRAS mutation colon- Prinotecan tumor recurrence Middle Aged HCT116 Cells colorectal-carcinoma Disease Progression Precipitation (chemical) RNA Cells cancer-patients a gene head and neck cancer 5-fluorouridine LN retrieval polymorphism human-leukocytes hepatic arterial NF-kappa B monoclonal-antibody centrosome amplification broccoli 1st-line treatment antibody-dependent cellular mu negative node colon cancer
Last updated on Wednesday, February 05, 2020